Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • API Reference

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Mercury NZ (MCY) / FY21

Result released17 August 2021·Annolyse analysis published22 April 2026

FY21 PBT fell 30.2% as EBITDAF dropped 6.3% on a 15.7% revenue lift

Higher revenue did not translate into earnings, leverage edged up to 2.9x EBITDAF, and the NPAT-based payout ratio reached 164.1%.

Energy & Utilities / Integrated gentailer

MCY metric context

Comparable chart history for this briefing.

Not enough chartable history yet. This panel will populate as comparable periods are published.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 20 July 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$9.5b

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

108.17x

i

Recent market cap compared with trailing earnings.

EPS

0.06

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

13.03x

i

Enterprise value compared with recent EBITDA.

P/FCF

Not available

i

Not available for this company right now.

P/B

1.98x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

3.7%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
17 August 2021
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

FY21 vs FY20

Revenue

$2b

Caveat: metric quality flags apply; use this value with basis context.

Net profit after tax

$141m

Caveat: metric quality flags apply; use this value with basis context.

Net cash inflow from operating activities

$338m

Caveat: metric quality flags apply; use this value with basis context.

Full-year dividend per share

17.0c

Caveat: metric quality flags apply; use this value with basis context.

Profit before tax

$173m

Caveat: metric quality flags apply; use this value with basis context.

Cash and cash equivalents

$163m

+106.3% ↑ vs $79m

Total assets

$8b

Caveat: metric quality flags apply; use this value with basis context.

Analysis ofMCY FY21·Result released17 August 2021·Annolyse analysis published22 April 2026

What changed

Mercury acquisition is result context, with NZ$7.8m acquisition price; operating metrics remain the main read

Mercury acquisition is result context, with NZ$441m initial cash proceeds; operating metrics remain the main read.

Revenue rose 15.7% to NZ$2b but EBITDAF fell 6.3% to NZ$463.0m and profit before tax dropped 30.2% to NZ$173.0m. The cleaner operating read is PBT: top-line growth did not flow through to earnings, with EBITDAF margin compressing from roughly 27.9% to 22.6% of revenue.

Reported NPAT of NZ$141.0m looks like a sharp jump only because the prior-period comparable in the structured form is distorted; against the like-for-like NZ$207.0m figure in release excerpts, NPAT fell about 32%, broadly consistent with PBT.

Operating cash flow eased 5.1% to NZ$338.0m while capex stepped down 10.4% to NZ$250.0m, lifting free cash flow 16.5% to NZ$282.0m. Gross borrowings rose NZ$200.0m to NZ$1.5b and net debt/EBITDAF moved from 2.5x to 2.9x.

What matters

Earnings compression despite revenue growth

  • EBITDAF down 6.3% on revenue up 15.7% points to negative operating leverage — consistent with the gentailer pattern of higher wholesale costs or hedge/generation mix absorbing customer-volume gains. This matters because revenue growth at this level should normally drop through, and it did not.

  • Leverage drift and a stretched payout. Net debt/EBITDAF rose to 2.9x from 2.5x, and the full-year dividend of 17.0 cents represents a payout ratio of 164.1% of NPAT versus 61.8% prior. FCF of NZ$282.0m still covers the ordinary dividend, but the NPAT-based cover has thinned materially and guidance points to a further dividend step-up next year.

  • Working capital absorbed cash. Trade debtors rose 29.0% to NZ$311.0m, lifting receivable days from 49.8 to 55.5 and adding roughly NZ$74.0m to operating working capital. This dampened cash conversion despite EBITDAF-to-OCF holding at 73.0% versus 72.1% prior.

Expectations

No quantified earnings target is supplied, so the result is best read against the HY21 shape

First-half EBITDAF of NZ$294.0m implied a much weaker second half of about NZ$169.0m, and first-half NPAT of NZ$130.0m left only around NZ$11.0m for the second half. That is a sharp second-half deceleration in a seasonally hydrology-sensitive business and frames the FY21 outcome as front-half loaded rather than evenly earned.

Forward dividend guidance of 20.0 cents implies a further step-up from the 17.0 cents declared, which raises the bar for FY22 earnings recovery and cash generation given current leverage.

Quality of result

The headline NPAT comparison is unreliable because the prior-period figure in the comparable extraction is distorted; PBT down 30.2% is the cleaner operating read

The effective tax rate moved modestly from 16.5% to 18.5%, so tax did not materially mask the underlying deterioration.

Cash quality is mixed. FCF rose to NZ$282.0m and equals 200.0% of reported NPAT, but a meaningful portion reflects lower capex (down NZ$29.0m) rather than stronger operating cash. The NZ$74.0m absorption into operating working capital, driven by a 5.7-day extension in receivable days, is a real drag and points to either customer-mix changes or collection timing that warrants monitoring. Capex intensity fell to 12.2% of revenue from 15.8%, which flatters near-term free cash but is unlikely to be the run-rate given disclosed growth-investment ambitions.

ROE fell to 3.4% from 5.5%, reinforcing that the equity base is being expanded faster than earnings — total equity rose NZ$447.0m while NPAT contracted on a like-for-like basis.

Unresolved

Open questions

Why did a 15.7% revenue uplift translate into a 6.3% EBITDAF decline, and how much reflects hydrology, wholesale pricing, or hedge book versus structural cost growth?
What is the expected normalised capex run-rate, and how does FY21's NZ$250.0m split between maintenance and growth project ahead?
How will the FY22 dividend guidance of 20.0 cents be reconciled with current NPAT-based cover and rising leverage at 2.9x net debt/EBITDAF?
What drove receivable days to 55.5 from 49.8, and is the working-capital absorption expected to reverse?
Why was second-half earnings so weak relative to the first half, and is that the new run-rate or a hydrology-driven trough?

This briefing cannot assess hydrology conditions, hedge book positioning, segment-level margin movements, or the financial impact of post-balance-date strategic actions, none of which are disclosed in usable form here.

Chat

Ask about MCY FY21

Ask follow-up questions about Mercury NZ's FY21 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about MCY FY21

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Mercury NZ's FY21 result.

Why did a 15.7% revenue uplift translate into a 6.3% EBITDAF decline, and how much reflects hydrology, wholesale pricing, or hedge book versus structural cost growth?Why does "Earnings compression despite revenue growth" matter?How strong was the cash and earnings quality in FY21?What should I watch next for MCY after FY21?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Annual report and financial statements FY2021

FY21 / financial report↗

Full year results presentation FY2021

FY21 / results presentation↗

News Release

FY21 / media release↗

Results Announcement FY2021

FY21 / results announcement↗

Prior comparable period

Annual report and financial statements FY2020

FY20 / financial report↗

News release

FY20 / media release↗

Results announcement FY2020

FY20 / results announcement↗

Interim context

2021 Interim Report including unaudited financial statements and Auditor's Review Report

HY21 / financial report↗

News Release

HY21 / media release↗

Results Announcement HY2021

HY21 / results announcement↗

Release context

Annual results webcast and teleconference details

FY21 / commentary↗

Media release - Mercury to acquire Trustpower retail

FY21 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by n/m, with a distortion flag in the result.

→

Dividend coverage and payout pressure

Dividend payout versus NPAT is 164.1%.

→

Cash conversion quality

This result converted 73.0% of EBITDA to operating cash flow, +0.9pp versus the prior comparable period.

→

Revenue growth context

Revenue growth was 15.7% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when MCY publishes next

Get the next Mercury NZ briefing and related NZX reporting-season updates by email.